Injectable Nanoparticulate Olanzapine Formulations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130309310A1
SERIAL NO

13950235

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described are injectable formulations of particulate olanzapine that produce a prolonged duration of action upon administration, and methods of making and using such formulations. The injectable formulations comprise particulate olanzapine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALKERMES PHARMA IRELAND LIMITED1 BURLINGTON ROAD CONNAUGHT HOUSE DUBLIN 4

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Czekai, David Spring City, US 19 240
Jenkins, Scott A Downingtown, US 60 5091
Liversidge, Elaine M Charlestown, US 6 275
Liversidge, Gary Charlestown, US 69 2095
Ruddy, Stephen B Schwenksville, US 53 2158

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation